Make your selection

List of Citicoline and group Neurodegenerative Disease intersectionsRows: 13■ Human ■ Animal ■ Risk ■ Review

SubstanceConditionSeqSrc
PMID
Dtl
Title
Citicoline Alzheimer's Disease
6
PM
38136170📋Memory Recovery Effect of a New Bioactive Innovative Combination in Rats with Experimental Dementia
Citicoline Alzheimer's Disease
2
PM
34870911📋[Citicoline in the treatment of cognitive impairment in first-degree relatives of AD patients: the influence of the ApoE genotype]
Citicoline Alzheimer's Disease
1
PM
33459645📋A Retrospective Study on the Benefits of Combined Citicoline, Memantine, and Acetylcholinesterase Inhibitor Treatments in Older Patients Affected with Alzheimer's Disease
Citicoline Alzheimer's Disease
3
PM
32538854📋Effects of Citicoline as an Adjunct Treatment for Alzheimer's Disease: A Systematic Review
Citicoline Alzheimer's Disease
4
PM
32447126📋The CITIMEM study: A pilot study. Optimizing pharmacological treatment in dementia
Citicoline Alzheimer's Disease
5
PM
28035929📋The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study
Citicoline Multiple Sclerosis
2
PM
34832936📋Regenerative Effects of CDP-Choline: A Dose-Dependent Study in the Toxic Cuprizone Model of De- and Remyelination
Citicoline Multiple Sclerosis
1
PM
33918331📋Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis
Citicoline Multiple Sclerosis
3
PM
25524711📋Pivotal role of choline metabolites in remyelination
Citicoline Neurodegenerative Disease
1
PM
34184483📋[Molecular and clinical aspects of the effect of cytidyndiphosphocholine on cognitive functions]
Citicoline Neurodegenerative Disease
2
PM
24736780📋Neuroprotective effects of citicoline in in vitro models of retinal neurodegeneration
Citicoline Parkinson's Disease
1
PM
33279231📋Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review
Citicoline Parkinson's Disease
2
PM
28805762📋[A study of combination treatment with nacom (levodopa + carbodope) and citicoline in the model of Parkinson disease in rats]